IBB vs TECL

iShares Biotechnology ETF vs Direxion Daily Technology Bull 3X ETF

Quick take
  • IBB has the lower expense ratio at 0.44% vs 0.87% for TECL.
  • TECL pays a higher dividend yield (5.71%).

Side-by-side metrics

MetricIBBTECL
Expense ratio
Annual fee. Lower is better.
0.44%0.87%
Dividend yield
Trailing 12-month yield.
0.23%5.71%
AUM
Assets under management — bigger funds are typically more liquid.
$7.95B$4.77B
YTD return
3.10%49.99%
1-year return
3-year return
Annualized.
5-year return
Annualized.
10-year return
Annualized.
Beta (3Y)
Volatility relative to the market. Closer to 1 = market-like.
0.744.36
P/E ratio
23.7241.79
Last price
$170.10$174.84
Inception
Issuer
iSharesDirexion

IBB top holdings

Top holdings · IBB
AMGNAmgen Inc7.37%
GILDGilead Sciences Inc7.32%
VRTXVertex Pharmaceuticals Inc7.21%
REGNRegeneron Pharmaceuticals Inc6.55%
ALNYAlnylam Pharmaceuticals Inc3.71%
ARGXargenx SE ADR3.33%
INSMInsmed Inc2.70%
BIIBBiogen Inc2.67%
NTRANatera Inc2.40%
RVMDRevolution Medicines Inc Ordinary Shares2.27%
Sector breakdown · IBB
Healthcare100.0%

TECL top holdings

Top holdings · TECL
NVDANVIDIA Corp10.05%
AAPLApple Inc8.25%
MSFTMicrosoft Corp6.27%
AVGOBroadcom Inc4.10%
Sector breakdown · TECL
Technology99.1%
Communication Services0.9%

About IBB

IBB (iShares Biotechnology ETF) is NASDAQ biotech and pharmaceutical companies. Managed by iShares, the fund carries $7.9B in assets under management, an expense ratio of 0.44%, a dividend yield of 0.23%. Its largest holding is Amgen Inc (AMGN), which represents 7.4% of the portfolio. Healthcare is the fund's largest sector exposure at 100.0%.

About TECL

TECL (Direxion Daily Technology Bull 3X ETF) is 3x daily performance of the S&P tech sector. Managed by Direxion, the fund carries $4.8B in assets under management, an expense ratio of 0.87%, a dividend yield of 5.71%. Its largest holding is NVIDIA Corp (NVDA), which represents 10.0% of the portfolio. Technology is the fund's largest sector exposure at 99.1%.